Sirio Pharma Co Ltd
SZSE:300791
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
|
Sirio Pharma Co Ltd
SZSE:300791
|
6.3B CNY |
Loading...
|
|
| FR |
|
L'Oreal SA
PAR:OR
|
198B EUR |
Loading...
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
110.1B GBP |
Loading...
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.2T INR |
Loading...
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
33.9B GBP |
Loading...
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
34.6B USD |
Loading...
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
18.3B EUR |
Loading...
|
|
| JP |
|
Kao Corp
TSE:4452
|
2.8T JPY |
Loading...
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.1T INR |
Loading...
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
855.7B INR |
Loading...
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD |
Loading...
|
Market Distribution
| Min | -409 046.1% |
| 30th Percentile | -1.4% |
| Median | 4.2% |
| 70th Percentile | 10.3% |
| Max | 876.4% |
Other Profitability Ratios
Sirio Pharma Co Ltd
Glance View
Sirio Pharma Co. Ltd. manufactures dietary supplement products. The company is headquartered in Shantou, Guangdong and currently employs 2,456 full-time employees. The company went IPO on 2019-09-25. The firm's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The firm's own brand is WEWOW nutritional health food. The firm distributes its products both in the domestic market and to overseas markets.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Sirio Pharma Co Ltd is 10.2%, which is below its 3-year median of 10.3%.
Over the last 3 years, Sirio Pharma Co Ltd’s Operating Margin has increased from 9.8% to 10.2%. During this period, it reached a low of 8.7% on Jun 30, 2023 and a high of 11.8% on Jun 30, 2024.
